98 results
Page 2 of 5
8-K
EX-10.1
m3gir 1iyl65
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.2
uzw scxpr7bjjb40s
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.3
jp9py9e
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.4
pggfet880381ke6 b0mf
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-1.1
ahzwsbr
19 Nov 21
Cyclo Therapeutics Announces Pricing of $11.7 Million Underwritten Public Offering of Common stock
4:04pm
8-K
EX-99.1
et5yxxmuy4k8kbz09jh
19 Nov 21
Cyclo Therapeutics Announces Pricing of $11.7 Million Underwritten Public Offering of Common stock
4:04pm
424B5
8vn3y itbokn02rtsx0p
18 Nov 21
Prospectus supplement for primary offering
4:31pm
424B5
qgtd8sbkhtok4zlz5fpg
16 Nov 21
Prospectus supplement for primary offering
4:36pm
8-K
EX-10.1
vp189 pl69ocmc7
16 Aug 21
Entry into a Material Definitive Agreement
4:52pm
424B5
5syngljmceao4
16 Aug 21
Prospectus supplement for primary offering
4:33pm
S-3/A
z4ertb6f
21 May 21
Shelf registration (amended)
4:19pm